Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heterologous Boost Third Dose of mRNA and Protein COVID-19 Vaccine
NCT05132855Phase 2Unknown
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Nov 2021
- Primary completion
- Apr 2023
- Modality
- Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of MVC-COV1901 in coronavirus disease 2019 (COVID-19), sponsored by Chang Gung Memorial Hospital. Status: unknown.
02
Drugs
MVC-COV1901
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05132855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05132855.